[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:TECH":3,"prompts:company:0000842023":22,"buybacks:0000842023:12":49,"months:0000842023:36":92,"side:events:0000842023":105,"filings:0000842023":124},{"status":4,"company":5,"choices":20,"suggestions":21},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":15,"coverage":16},"0000842023","Bio-Techne Corp.","TECH","NASD",[11],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NASD:TECH","Common Stock",null,false,{"buybacks":17},{"published":18,"published_at":19},true,"2026-11-17",[],[],{"placement":23,"items":24},"company",[25,30,34,38,44],{"id":26,"title":27,"hint":28,"kind":29,"question":27,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":31,"title":32,"hint":33,"kind":29,"question":32,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":35,"title":36,"hint":37,"kind":29,"question":36,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":39,"title":40,"hint":41,"kind":42,"question":14,"target":43},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":45,"title":46,"hint":47,"kind":48,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"company":50,"data_as_of":51,"checked_at":52,"has_active_program":18,"authorized_total":53,"remaining_total":61,"nearest_expiration":64,"programs":66,"recent_quarters":83,"did_asr":15,"asrs":91},{"cik":6,"name":7,"ticker":8,"exchange":9},"2026-09-30","2026-11-18T00:41:43.190713Z",{"value":54,"status":55,"as_of":51,"source":56},505000000,"reported",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"0001104659-26-123907","10-Q","2026-11-06","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F842023\u002F000110465926123907\u002F",{"value":62,"status":55,"as_of":51,"source":63},363332959,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":14,"status":65,"as_of":14,"source":14},"not_found",[67],{"authorized":68,"unit":70,"authorized_as_stated":71,"price_as_of":14,"date_authorized":73,"expiration_date":76,"remaining":77,"remaining_as_stated":80,"description":82},{"value":54,"status":55,"as_of":51,"source":69},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"usd",{"value":54,"status":55,"as_of":51,"source":72},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":74,"status":55,"as_of":51,"source":75},"2025-04-30",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":14,"status":65,"as_of":14,"source":14},{"value":62,"status":78,"as_of":51,"source":79},"estimated",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":62,"status":78,"as_of":51,"source":81},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"the Board approved a new share repurchase plan on April 30, 2025, to replace the previous share repurchase plan, that authorizes the Company to purchase up to $505 million of the Company’s outstanding common stock.",[84],{"period_start":85,"period_end":51,"shares":86,"avg_price":14,"value_usd":86,"source":87},"2026-07-01",0,{"accession":88,"form":58,"as_of":51,"filed_at":89,"url":90},"0001104659-26-126284","2026-11-12","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F842023\u002F000110465926126284\u002F",[],{"company":93,"data_as_of":51,"items":94},{"cik":6,"name":7,"ticker":8,"exchange":9},[95,98,102],{"period_start":85,"period_end":96,"open_market_shares":86,"total_shares":86,"program_shares":86,"asr_shares":14,"avg_price":86,"value_usd":86,"remaining":62,"remaining_unit":70,"source":97},"2026-07-31",{"accession":88,"form":58,"as_of":51,"filed_at":89,"url":90},{"period_start":99,"period_end":100,"open_market_shares":86,"total_shares":86,"program_shares":86,"asr_shares":14,"avg_price":86,"value_usd":86,"remaining":62,"remaining_unit":70,"source":101},"2026-08-01","2026-08-31",{"accession":88,"form":58,"as_of":51,"filed_at":89,"url":90},{"period_start":103,"period_end":51,"open_market_shares":86,"total_shares":86,"program_shares":86,"asr_shares":14,"avg_price":86,"value_usd":86,"remaining":62,"remaining_unit":70,"source":104},"2026-09-01",{"accession":88,"form":58,"as_of":51,"filed_at":89,"url":90},{"view":106,"sort":107,"total":108,"generated_at":109,"items":110,"next_cursor":14},"all","newest",2,"2026-11-20T09:58:33.467888Z",[111,117],{"id":112,"type":113,"event_date":74,"company":114,"amount_usd":54,"amount_estimated":15,"shares":14,"headline":115,"source":116},"1528a961-d78c-5d5f-a825-78104b865446","authorization_new",{"cik":6,"name":7,"ticker":8,"exchange":9},"Bio-Techne Corp. authorizes $505m share repurchase program",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"id":118,"type":113,"event_date":119,"company":120,"amount_usd":121,"amount_estimated":15,"shares":14,"headline":122,"source":123},"13764c0c-9c73-528f-9be2-84474b81f843","2022-02-02",{"cik":6,"name":7,"ticker":8,"exchange":9},400000000,"Bio-Techne Corp. authorizes $400m share repurchase program",{"accession":88,"form":58,"as_of":51,"filed_at":89,"url":90},{"company":125,"items":126,"edgar_url":137},{"cik":6,"name":7,"ticker":8,"exchange":9},[127,132],{"accession":88,"form":128,"filed_at":129,"period_end":51,"url":90,"used_for":130},"10-Q\u002FA","2026-11-12T16:31:23Z",[131],"recent_quarters",{"accession":57,"form":58,"filed_at":133,"period_end":51,"url":60,"used_for":134},"2026-11-06T16:30:50Z",[135,136],"programs","remaining_total","https:\u002F\u002Fwww.sec.gov\u002Fcgi-bin\u002Fbrowse-edgar?action=getcompany&CIK=0000842023"]